RavenQuest BioMed Inc. announced it has appointed Dr. Simerjeet Kaur, PhD, to lead Scientific Research & Development. Dr. Kaur will lead the company's R&D and scientific training efforts, specifically relating to the development of new high yielding, stress resistant Cannabis varieties for medicinal as well as recreational purposes. Dr. Kaur is a leader in her field. RavenQuest is thrilled to bring an accomplished and highly respected plant breeder and geneticist onboard. In assembling its senior team members, its focus has been upon attracting thought leaders with proven results in their respective fields. The addition of Dr. Kaur is yet another example of this. The addition of Dr. Kaur, combined with McGill University research partnership, positions RavenQuest to lead the cannabis industry with stable, high yielding cannabis expression based in science, stated George Robinson, CEO of RavenQuest. As its industry matures, it's important to deliver a consistent, repeatable experience for its end users while maximizing plant yields that keep margins healthy for shareholders. To that end, Dr. Kaur's expertise is instrumental to RavenQuest as the company continue to build a very unique cannabis company.